Matches in Wikidata for { <http://www.wikidata.org/entity/Q81816352> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q81816352 description "article scientifique publié en 2005" @default.
- Q81816352 description "artículu científicu espublizáu n'agostu de 2005" @default.
- Q81816352 description "im August 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81816352 description "scientific article published on 01 August 2005" @default.
- Q81816352 description "wetenschappelijk artikel" @default.
- Q81816352 description "наукова стаття, опублікована в серпні 2005" @default.
- Q81816352 name "Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma" @default.
- Q81816352 name "Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma" @default.
- Q81816352 type Item @default.
- Q81816352 label "Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma" @default.
- Q81816352 label "Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma" @default.
- Q81816352 prefLabel "Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma" @default.
- Q81816352 prefLabel "Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma" @default.
- Q81816352 P1433 Q81816352-196285F7-BDFD-4DAC-AF8E-B6626D3BDE28 @default.
- Q81816352 P1476 Q81816352-EFCEA724-28E0-4924-85E3-3E2B6266CEF9 @default.
- Q81816352 P2093 Q81816352-123494AD-E433-47F7-B0FC-CDAF2A1BE2D4 @default.
- Q81816352 P2093 Q81816352-36D15C20-B807-4356-A347-480C3E752701 @default.
- Q81816352 P2093 Q81816352-3F5FD024-C643-417F-B4BD-F58CE7ED0910 @default.
- Q81816352 P2093 Q81816352-48453558-F7E0-4781-BC5B-CF1DC10A9433 @default.
- Q81816352 P2093 Q81816352-B602E2A4-06E2-46A1-8E8F-6E5E18B0FD5F @default.
- Q81816352 P2093 Q81816352-CDEB51B2-6A5C-4DBD-9544-245B99B4D213 @default.
- Q81816352 P2860 Q81816352-00474C27-750E-499C-AEF1-6D84347D3B21 @default.
- Q81816352 P2860 Q81816352-215786EF-60A8-4AEC-979B-9121FE0C4AA9 @default.
- Q81816352 P2860 Q81816352-5E85E293-7AA2-4C2E-8CCC-4DC6C34388D3 @default.
- Q81816352 P2860 Q81816352-A3E745DA-ECB4-42CD-B979-B9C24EC7C8BD @default.
- Q81816352 P2860 Q81816352-ACDC6D6E-0ED1-456D-94DA-5D67E67CDFE8 @default.
- Q81816352 P2860 Q81816352-BB186F83-A679-4E16-9E8B-454D7F054316 @default.
- Q81816352 P2860 Q81816352-DA2716CF-AC8B-42DA-B656-90DB95DE0C1A @default.
- Q81816352 P2860 Q81816352-DFBA6C8E-881B-4229-81FB-8E8B5D704F58 @default.
- Q81816352 P2860 Q81816352-FA87120D-8F57-4A6E-A7F4-431DC45D6603 @default.
- Q81816352 P2888 Q81816352-60A118D7-84D6-4CFD-9F0A-2572DD2FEF04 @default.
- Q81816352 P304 Q81816352-FBE6DC06-A053-40C1-BC60-A5E8F63E8B24 @default.
- Q81816352 P31 Q81816352-784A4C4E-1532-43F0-AF80-121DABAB32F1 @default.
- Q81816352 P356 Q81816352-786EFBC6-86FA-431E-95BD-783C71C4CA8C @default.
- Q81816352 P433 Q81816352-60B9DD75-4106-47A0-93EA-C1FFC46A40B3 @default.
- Q81816352 P478 Q81816352-70E74C82-95E7-4BD8-822F-596548FA58F3 @default.
- Q81816352 P577 Q81816352-9DEB3989-0C88-4C5A-9F90-C68CC5CF30E0 @default.
- Q81816352 P6179 Q81816352-087B2A9C-58B9-4F8C-ADAC-F8B24A37FD45 @default.
- Q81816352 P698 Q81816352-83EBA86C-59F5-489B-988A-5B91127C9AF1 @default.
- Q81816352 P921 Q81816352-E53770FD-39BC-40C4-8A25-5EF44A428E68 @default.
- Q81816352 P356 SJ.BMT.1705036 @default.
- Q81816352 P698 15937499 @default.
- Q81816352 P1433 Q4941523 @default.
- Q81816352 P1476 "Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma" @default.
- Q81816352 P2093 "B Chapuy" @default.
- Q81816352 P2093 "B Glass" @default.
- Q81816352 P2093 "G G Wulf" @default.
- Q81816352 P2093 "J Hasenkamp" @default.
- Q81816352 P2093 "L Truemper" @default.
- Q81816352 P2093 "W Jung" @default.
- Q81816352 P2860 Q28215194 @default.
- Q81816352 P2860 Q33330761 @default.
- Q81816352 P2860 Q43864036 @default.
- Q81816352 P2860 Q44372685 @default.
- Q81816352 P2860 Q44834795 @default.
- Q81816352 P2860 Q44915322 @default.
- Q81816352 P2860 Q44992737 @default.
- Q81816352 P2860 Q53634516 @default.
- Q81816352 P2860 Q73828898 @default.
- Q81816352 P2888 sj.bmt.1705036 @default.
- Q81816352 P304 "271-273" @default.
- Q81816352 P31 Q13442814 @default.
- Q81816352 P356 "10.1038/SJ.BMT.1705036" @default.
- Q81816352 P433 "3" @default.
- Q81816352 P478 "36" @default.
- Q81816352 P577 "2005-08-01T00:00:00Z" @default.
- Q81816352 P6179 "1019844375" @default.
- Q81816352 P698 "15937499" @default.
- Q81816352 P921 Q65592366 @default.